At a glance
ClinicalIndex Comparison RecordN/ACompleted· 118 enrolled
Drug / intervention
Decreased opiate prescription +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized-controlled Trial of Post-operative Opiate Quantities After Urogynecologic Surgery
In Brief
A clinical study evaluating Decreased opiate prescription and Routine opiate prescription for Postoperative Pain and Opioid Use. Completed, enrolled 118 participants across 1 site.
Detailed Summary
This is a randomized controlled trial to determine the effect of decreased post-operative prescriptions of opiate medications after urogynecologic surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain, Opioid Use
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartOct 2017
First PostedOct 2017
Primary CompletionApr 2019
Study CompletionJun 2019
TodayJul 2026
First PostedOct 24, 2017
Enrollment StartOct 13, 2017
Primary CompletionApr 30, 2019
Study CompletionJun 25, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.7 years ago
Interventions
Decreased opiate prescriptionother
The experimental group will receive 5 tablets of oxycodone 5mg at time of discharge with a paper backup prescription for an additional 10 tablets.
Routine opiate prescriptionother
The comparator group will receive 28 tablets of oxycodone 5mg at time of discharge.